Long COVID Drug
Activist Investors Renew Battle Against Biotech Pioneering Long COVID Treatment at AIM Immunotech
Anika Sharma
In the ever-shifting landscape of corporate battles, AIM Immunotech finds itself once again on the front lines, grappling with a ...
